MedElevator Войти в исследования
← Поиск публикаций

DOI 10.1016/j.jacep.2023.01.011

Медицинская библиотека · JACC. Clinical electrophysiology · 2023

Long-Term Outcome of ICD Therapy in Patients With Noncompaction Cardiomyopathy Compared With DCM and HCM.

Kaya Emrah, Otten Martijn, Theuns Dominic A M J, Veen Kevin, Yap Sing-Chien, Schinkel Arend F L, Constantinescu Alina A, Michels Michelle, Manintveld Olivier C, Szili-Torok Tamas, Caliskan Kadir

СтатьяПеревод пока не подготовлен

Аннотация

BACKGROUND

Implantable cardioverter-defibrillators (ICDs) are frequently used for primary and secondary prevention in patients with cardiomyopathies due to different etiologies. However, long-term outcome studies in patients with noncompaction cardiomyopathy (NCCM) are scarce.

OBJECTIVES

This study summarizes the long-term outcome of ICD therapy in patients with NCCM compared with those with dilated cardiomyopathy (DCM) or hypertrophic cardiomyopathy (HCM).

METHODS

Prospective data from our single-center ICD registry were used to analyze the ICD interventions and survival in patients with NCCM (n = 68) compared with patients with DCM (n = 458) and patients with HCM (n = 158) from January 2005 to January 2018.

RESULTS

This NCCM population with an ICD for primary prevention comprised 56 (82%) patients with a median age of 43 years and 52% males, compared with 85% in patients with DCM and 79% in patients with HCM (P = 0.20). During a median follow-up of 5 years (IQR: 2.0-6.9 years), appropriate and inappropriate ICD interventions were not significantly different. Nonsustained ventricular tachycardia during Holter monitoring in patients with NCCM was the only significant risk factor for appropriate ICD therapy in patients with NCCM, with a HR of 5.29 (95% CI: 1.12-24.96). The long-term survival was significantly better in the univariable analysis in the NCCM group. However, there was no difference in multivariable Cox regression analyses between the cardiomyopathy groups.

CONCLUSIONS

At 5 years of follow-up, the rate of appropriate and inappropriate ICD interventions in NCCM was comparable to that in DCM or HCM. In multivariable analysis, no differences in survival were found between the cardiomyopathy groups.

Для цитирования: Kaya Emrah, Otten Martijn, Theuns Dominic A M J, Veen Kevin, Yap Sing-Chien, Schinkel Arend F L, Constantinescu Alina A, Michels Michelle, Manintveld Olivier C, Szili-Torok Tamas, Caliskan Kadir. Long-Term Outcome of ICD Therapy in Patients With Noncompaction Cardiomyopathy Compared With DCM and HCM.. JACC. Clinical electrophysiology. 2023. DOI: 10.1016/j.jacep.2023.01.011.

Предметные рубрики MeSH

Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…

История · было → стало

Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.

Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.